Mental Health Diagnosis and Stigma: How Modern Frameworks Shape Public Perception

Introduction

Contemporary diagnostic frameworks play a crucial role in mental health practice, research, and policy. Systems like DSM-5-TR and ICD-11 offer a common language for comprehending mental distress, helping to inform clinical decisions, service delivery, and public discussions (American Psychiatric Association, 2022; WHO, 2019). Nevertheless, stigma related to mental health, which is characterised by negative attitudes, stereotypes, and discriminatory actions towards individuals with mental disorders, continues to pose a significant obstacle to seeking help, recovery, and social integration (Corrigan & Watson, 2002; Link & Phelan, 2001). The connection between diagnosis and stigma is complex and non-linear.

Diagnostic labels can validate experiences of suffering, decrease moral culpability, and ease access to treatment and legal support. Yet they may also reinforce essentialist views of mental illness, promote social distancing, and contribute to public and self-stigma (Ben-Zeev et al., 2010; Haslam et al., 2005). Diagnosis, therefore, functions as both a gateway to care and a potential source of harm depending on interpretation and application.

This essay examines the relationship between contemporary diagnostic systems and mental health stigma by reviewing theoretical mechanisms and empirical evidence. It explores how diagnosis shapes stigma through labelling, categorisation, and biomedical explanations, considers evidence that frameworks can both reduce and exacerbate stigma, and evaluates DSM-5-TR and ICD-11 reforms addressing these issues. Overall, diagnostic frameworks have context-dependent effects on stigma, influenced by clinical communication, sociocultural factors, and the rigidity of diagnostic categories.

Diagnostic frameworks and forms of mental health stigma

Diagnostic frameworks are formally developed systems used to classify mental disorders based on patterns of symptoms, their duration, and the degree of functional impairment. Both the DSM-5-TR and ICD-11 primarily use categorical approaches, though recent updates have added dimensional elements to better capture the severity and variation of symptoms (American Psychiatric Association, 2022). Mental health stigma is often understood in three interconnected forms: public stigma, which reflects societal stereotypes and prejudice; self-stigma, which occurs when individuals internalise these negative beliefs; and structural stigma, which refers to institutional policies and practices that disadvantage people with mental disorders (Corrigan & Watson, 2002; Link & Phelan, 2001). Diagnostic frameworks influence all three forms by shaping the language used to describe mental illness, guiding professional authority, and determining access to services and resources.

Two major theoretical perspectives help explain how psychiatric diagnoses may influence stigma. Labelling theory suggests that psychiatric diagnoses act as socially meaningful labels that can increase stereotyping, status loss, and discrimination by marking individuals as members of a devalued group. This perspective draws on the work of Link and Phelan (2001), who describe stigma as a social process in which labelling, stereotyping, and separation contribute to disadvantage in a context of power. In contrast, attribution theory proposes that medicalising mental disorders can reduce stigma by framing symptoms as involuntary and biologically determined, thereby decreasing perceived personal blame. This idea is supported by Corrigan and Watson (2002), who show that biological explanations of mental illness can mitigate negative societal judgments and self-stigma. Contemporary diagnostic systems therefore occupy a tension between legitimising distress as a health condition and reinforcing categorical boundaries that, if applied rigidly, may inadvertently foster stigma.

Evidence suggesting diagnostic frameworks may reduce stigma

Diagnostic frameworks can legitimise mental distress and promote parity with physical health. Biomedical explanations reduce attributions of personal responsibility and moral weakness, shifting attitudes away from blame (Corrigan & Watson, 2002). Vignette studies show that describing depression or schizophrenia in clinical diagnostic terms decreases character attributions and increases support for professional treatment (Rüsch et al., 2005). Overall, diagnosis primarily reduces public stigma related to blame by framing symptoms as health conditions rather than personal failings.

Diagnosis also facilitates access to care, indirectly influencing stigma. Formal diagnoses act as gateways to treatment, insurance coverage, workplace accommodations, and specialist services, reducing barriers to help-seeking (Corrigan et al., 2014). For individuals with lived experience, diagnosis can foster understanding and reduce self-blame, particularly when clinicians communicate diagnoses collaboratively and emphasise hope, strengths, and recovery (Dinos et al., 2004; Horn et al., 2007).

At a structural level, standardised diagnostic systems support advocacy, policy, and resource allocation. Including mental disorders in ICD-11 positions them alongside physical illnesses, reinforcing legitimacy in global health planning (WHO, 2019). Cross-national research indicates that countries with stronger mental health policies report less exclusion in employment and healthcare (Thornicroft et al., 2016). Although causality cannot be assumed, the consistency of these findings suggests that diagnostic legitimacy is a necessary but insufficient condition for stigma reduction.

Evidence that diagnostic labelling can exacerbate stigma

Despite the potential benefits of diagnosis, psychiatric labels can also increase stigma. Labelling theory suggests that diagnostic categories can heighten social distancing and perceptions of dangerousness, particularly for psychotic disorders (Link & Phelan, 2001; Rüsch et al., 2005). Biomedical explanations within these frameworks may further reinforce beliefs that mental disorders are chronic, unpredictable, and categorically different, contributing to fear and exclusion (Loughman & Haslam, 2018). DSM-based labels can also enhance perceptions of groupness and homogeneity, making individuals appear more alike and permanently distinct (Ben-Zeev et al., 2010). These processes can intensify public stigma and drive label avoidance, where people delay or avoid help to escape social consequences (Ben-Zeev et al., 2010).

Public stigma is resistant to reduction through diagnostic knowledge alone. Longitudinal research shows that greater endorsement of neurobiological and diagnostic explanations does not reliably reduce social distance and may coincide with persistent or worsening stigma (Corrigan et al., 2014; Loughman & Haslam, 2018). Diagnostic classification can also reinforce perceptions of “differentness” and non-recovery, maintaining social exclusion even when symptoms are well managed (Corrigan, 2007).

Self-stigma is another domain where diagnosis can have unintended negative effects. Individuals who strongly identify with diagnostic labels are more likely to internalise negative stereotypes, lowering self-esteem, hope, and recovery outcomes (Corrigan et al., 2014). Quantitative studies also link higher self-labelling to reduced psychosocial functioning independent of symptom severity, especially when diagnoses are framed as fixed or defining (Rüsch et al., 2005). These findings suggest that while diagnosis can validate distress, rigid application may constrain identity and agency.

Contemporary reforms and dimensional approaches

In response to concerns about stigma, contemporary diagnostic frameworks have introduced reforms aimed at reducing potential harms. DSM-5-TR and ICD-11 increasingly promote person-centred and culturally informed diagnostic practices, reflecting a shift away from rigid categorical models (Wallin et al., 2022; WHO, 2019). Dimensional approaches conceptualise mental disorders along continua rather than discrete categories, which may weaken perceived boundaries between “normal” and “abnormal”. Empirical evidence indicates that dimensional descriptions are associated with lower essentialist beliefs and reduced social distance compared with categorical labels (Haslam et al., 2004).

ICD-11 has revised diagnostic terminology to remove overtly stigmatising language, notably replacing “mental retardation” with “intellectual developmental disorder” (WHO, 2019). Experimental studies suggest such changes can improve attitudes among professionals and trainees, but evidence for sustained reductions in public stigma is limited, indicating that terminology reform alone is insufficient to counter entrenched stereotypes.

Cultural sensitivity represents another important area of reform, as contemporary frameworks increasingly acknowledge sociocultural variation in symptom expression and meaning. This is particularly relevant to stigma, given that misdiagnosis and cultural invalidation contribute to marginalisation. Cross-cultural research suggests that culturally responsive mental health practices, including diagnostic approaches, are associated with greater service engagement and lower perceived stigma among minority groups (Thornicroft et al., 2016). Nonetheless, critics argue that global diagnostic systems continue to reflect predominantly Western models of mental illness, risking the persistence of structural stigma.

Critical evaluation of the evidence

Although diagnostic frameworks can both mitigate and exacerbate stigma, their effects are neither uniform nor linear. Evidence that diagnostic explanations reduce blame primarily comes from vignette-based studies capturing short-term attitudinal shifts rather than real-world behaviour, limiting ecological validity (Corrigan & Watson, 2002; Rüsch et al., 2005). Longitudinal and population-level research indicates that endorsement of biomedical or diagnostic models does not consistently reduce stigma and may reinforce essentialist beliefs about permanence and difference (Loughman & Haslam, 2018; Corrigan et al., 2014). Overall, diagnostic frameworks appear to reduce blame more reliably than social distance, while biogenetic framings can inadvertently heighten perceptions of chronicity and dangerousness.

These effects vary by diagnosis. For example, stigma differs between depression and schizophrenia and in how clinicians present the label. Framing symptoms in person-first, non-deterministic terms can reduce blame and self-stigma, showing how theory operates in practice.

Much of the literature treats diagnostic frameworks as static, under-examining how clinician communication, institutional practices, and sociocultural context moderate their effects (Link & Phelan, 2001; Thornicroft et al., 2016). While DSM-5-TR and ICD-11 reforms, including dimensional models and person-first language, aim to mitigate stigma, evidence of their effectiveness in everyday clinical and societal contexts remains limited (American Psychiatric Association, 2022; WHO, 2019).

The evidence supports a conditional relationship between diagnosis and stigma: diagnostic frameworks can both alleviate and exacerbate stigma depending on how they are applied, communicated, and interpreted within broader social and institutional contexts.

Conclusion

This essay has examined the relationship between contemporary diagnostic frameworks and mental health stigma through both theoretical and empirical perspectives. Systems such as DSM-5-TR and ICD-11 play an ambivalent role. They can legitimise mental distress, reduce moral blame, and facilitate access to care, benefiting public, self, and structural stigma (Corrigan et al., 2014; Thornicroft et al., 2016). Conversely, diagnostic labels can reinforce essentialist beliefs, social distancing, self-stigma, and label avoidance, particularly when biomedical explanations are presented without nuance (Ben-Zeev et al., 2010; Corrigan, 2007; Loughman & Haslam, 2018). 

Reforms emphasising dimensional approaches, person-first language, and cultural sensitivity are important steps in reducing stigma, with implications for policy, anti-stigma initiatives, and clinical practice. Contemporary diagnostic frameworks are neither inherently stigmatising nor liberating; their impact depends on how they are understood, communicated, and applied. Ongoing evaluation and the meaningful inclusion of lived-experience perspectives are essential to ensure that diagnosis supports mental health equitably. Evidence shows that collaborative diagnostic discussions can reduce self-blame and promote help-seeking without reinforcing stigma.

Dr Krishna Athal Life & Executive Coach | Corporate Trainer | Leadership Consultant

Dr Krishna Athal is an internationally acclaimed Life & Executive Coach, Corporate Trainer, and Leadership Consultant with a proven track record across India, Mauritius, and Singapore. Widely regarded as a leading voice in the field, he empowers individuals and organisations to unlock potential and achieve lasting results.

See Full Bio

Life & Executive Coaching Life Coaching Executive Coaching Corporate Training